Balyasny Asset Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Hold |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $6.2M | Sell |
|
|||||
|
2024
Q2 | $32.6M | Sell |
|
|||||
|
2024
Q1 | $47.3M | Buy |
|
|||||
|
2023
Q4 | $34.5M | Sell |
|
|||||
|
2023
Q3 | $34.7M | Buy |
|
|||||
|
2023
Q2 | $35M | Buy |
|
|||||
|
2023
Q1 | $33.5M | Buy |
|
|||||
|
2022
Q4 | $40.4M | Buy |
|
|||||
|
2022
Q3 | $13.7M | Buy |
|
|||||
|
2022
Q2 | $7.41M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $452K | Sell |
|
|||||
|
2021
Q3 | $1.32M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $2.71M | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $162K | Sell |
|
|||||
|
2017
Q3 | $12.2M | Buy |
|
|||||
|
2017
Q2 | $7.64M | Buy |
|
|||||
|
2017
Q1 | $6.52M | Buy |
|
|||||
|
2016
Q4 | $3.96M | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $1.25M | Sell |
|
|||||
|
2015
Q4 | $2.43M | Buy |
|